A merger headline can describe what shareholders receive without describing what a listed option will deliver. Lantheus is a useful example of why those two questions need separate answers. The proposed transaction includes a contingent component for shareholders, while the anticipated options adjustment has a narrower settlement package.
For an investor comparing stock ownership with a call option, that distinction changes the meaning of exposure to the deal. A contract can reference the same company while carrying different rights at a corporate-action boundary. Understanding the instrument matters as much as understanding the acquisition announcement.
What OCC has announced
OCC Information Memo 59732, dated September 9, 2026, describes an anticipated LNTH adjustment following the proposed Curium transaction. The shareholder vote is scheduled for October 14. If the merger closes, the memo specifies a USD 10,250 cash deliverable per contract and expressly excludes the non-transferable contingent value rights, or CVRs. Cash settlement would reflect the difference between that deliverable and the extended strike amount.
The adjustment would take effect on the business day after consummation, currently anticipated in the first half of 2027. OCC also identifies expiration acceleration for cash-only contracts. It does not provide a final adjustment date or a specific accelerated expiration in this notice. Call holders seeking shareholder CVRs are directed to consider exercise sufficiently ahead of the adjustment, with timing their responsibility.
The shareholder package is conditional
Curium’s August 3 announcement describes USD 102.50 per share at closing, plus non-transferable CVRs with potential additional payments of up to USD 12 per share. Those contingent payments depend on commercial milestones through 2030. Curium says there is no assurance any CVR payment will occur. Completion remains subject to shareholder and regulatory approvals and other closing conditions.
The maximum advertised consideration therefore combines two different economic components: closing cash and an uncertain future entitlement. Treating the maximum as cash already available would collapse that distinction. A milestone right also has a different time horizon from an option that may expire much earlier. Neither the maximum potential payment nor the expected closing period establishes a current fair value for the stock or a particular contract.
Why It Matters For Options Traders
The immediate analytical task is to identify the claim being valued. Does a valuation describe shares, a listed call, an adjusted cash obligation, or a contingent payment right? A model that starts with the wrong claim can produce a precise answer to the wrong question. This is particularly relevant when an acquisition price is quoted as a single combined number.
An investor can organize the review around three separate documents: the transaction terms, the options adjustment notice, and the broker’s operational instructions. Each addresses a different question. The first explains the corporate consideration, the second defines the clearing treatment, and the third explains how an account can act within the applicable process. Agreement on a headline price does not make those documents interchangeable.
This is educational analysis, not a suggestion to exercise, buy shares, or sell a contract. There is no universal action that follows merely from identifying a difference in rights. The economic comparison also depends on the price paid, remaining option value, available capital, costs, and the investor’s ability to hold the resulting position.
Exercise changes the position
OIC explains that American-style equity calls can be exercised before expiration, subject to brokerage procedures. Exercise commits the holder to purchasing shares at the strike and generally requires the necessary capital or margin capacity. It also gives up remaining time value. Selling an option and exercising it are different transactions; their proceeds and resulting exposures need not match.
Broker cutoffs can be earlier than exchange deadlines. A date on a public notice is therefore insufficient to determine the last usable instruction time for a particular account. Confirmation of the broker’s process is part of understanding the transaction, especially around a corporate action.
The site’s guide to expiration, assignment and exercise provides background on these distinctions. The important question is what position exists after an instruction has been processed, rather than simply whether the option appeared valuable on a screen beforehand.
Short positions and spreads need separate attention
OIC’s assignment guidance explains that a short American-style option can be assigned when a holder of the same series exercises. Assignment is not tied to the original buyer on the other side of a trade. Nor is a quoted in-the-money threshold an absolute guarantee of what every holder will do.
FINRA also emphasizes that a short leg’s obligation survives independently of the investor’s broader spread. Owning a protective option does not itself instruct the broker to exercise that option. An assignment can create a stock or delivery obligation that requires separate handling, even where an expiration payoff diagram appears bounded.
The resulting review should cover each leg’s instrument, quantity, expiration, deliverable and account treatment. That is a mechanics check, not a forecast that an assignment will occur. Readers can use the site’s early-assignment explanation for the general framework.
Common misunderstandings and caveats
An anticipated notice is not evidence that a merger has closed. A vote, an expected completion period, an effective adjustment and the final exercise schedule are separate milestones. Subsequent official notices are needed to resolve dates that remain open; a calendar estimate should not be promoted into a deadline.
Cash-only adjustments also change the usual option-pricing context. OIC explains that once a deliverable becomes fixed cash, ordinary trading generally ceases and in-the-money contracts lose their time-value component. That general description applies after the relevant adjustment, not automatically when a proposed acquisition is announced. Before completion, uncertainty about the transaction still matters.
Finally, labels such as “covered” or “hedged” do not settle every operational question. A position can have a familiar strategy name while its component contracts require a fresh review after a corporate action. A useful record identifies which notice supplied each term and which details remain unresolved. It should distinguish an observed contract specification from an assumption carried over from a standard option.
This is not financial advice. Options trading involves risk and is not suitable for all investors. This article is market commentary and education, not a recommendation or a valuation of LNTH or its contingent rights. Investors should review the standardized-options risk disclosure and their broker’s exercise, assignment and margin procedures.
Sources
OCC, Information Memo 59732, September 9, 2026:
https://infomemo.theocc.com/infomemos?number=59732
Curium, definitive agreement announcement, August 3, 2026:
https://www.curiumpharma.com/2026/08/03/curium-merge-lantheus/
OIC, Options Exercise:
https://www.optionseducation.org/referencelibrary/faq/options-exercise
OIC, Options Assignment:
https://www.optionseducation.org/referencelibrary/faq/options-assignment
FINRA and OCC, Trading Options: Understanding Assignment:
https://syndication.finra.org/content/trading-options-understanding-assignment
OIC, Splits, Mergers, Spinoffs and Bankruptcies:
https://www.optionseducation.org/referencelibrary/faq/splits-mergers-spinoffs-bankruptcies
